TLX

Telix Pharmaceuticals Limited (TLX), the Australia-based radiopharmaceutical company, is seeing heightened interest in its stock price, quotes and trading history as investors look up the latest news on the company. No specific corporate development is attached to the surge in searches, but the biotech has been a regular subject of market coverage given its pipeline of imaging and therapeutic candidates.